Opium: An emerging risk factor for gastric adenocarcinoma

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD,USA.
International Journal of Cancer (Impact Factor: 6.2). 01/2013; 133(2). DOI: 10.1002/ijc.28018
Source: PubMed

ABSTRACT Opium use has been associated with higher risk of cancers of the esophagus, bladder, larynx, and lung;however, no previous study has examined itsassociation with gastric cancer. There is also little information on the associations between hookah (water pipe) smokingorthe chewing of tobacco productsand the risk of gastric cancer. In a case-control study in Golestan Province of Iran, we enrolled 309 cases of gastric adenocarcinoma (118noncardia, 161 cardia, and 30 mixed-locationadenocarcinomas) and 613 matched controls. Detailed information on long-term use of opium, tobacco products, and other covariates were collected using structured and validated lifestyle and food frequency questionnaires. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were obtained using conditional logistic regression models. Opium use was associated with an increased risk of gastric adenocarcinoma, with an adjusted OR (95% CI) of 3.1 (1.9 - 5.1), and this increased risk was apparent for both anatomic subsites (cardia andnoncardia). There was a dose-response effect, and individuals with the highest cumulative opium use had the strongest association (OR: 4.5; 95%CI: 2.3-8.5). We did not find a statistically significant association between the use of any of the tobacco products and risk of gastric adenocarcinoma, overall or by anatomic subsite.We showed, for the first time, an association between opium use and gastric adenocarcinoma. Given that opium use is a traditional practice in many parts of the world, these results are of public health significance. © 2013 Wiley Periodicals, Inc.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Less than a century ago, gastric cancer (GC) was the most common cancer in the United States and perhaps throughout the world. Despite its worldwide decline in incidence over the past century, GC remains a major killer across the globe. This article reviews the epidemiology, screening, and prevention of gastric cancer. We first discuss the descriptive epidemiology of GC, including its incidence, survival, and mortality, including trends over time. Next, we characterize the risk factors for gastric cancer, both environmental and genetic. Serological markers and histological precursor lesions of GC and early detection of GC of using these markers is reviewed. Finally, we discuss prevention strategies and provide suggestions for further research.
    Cancer Epidemiology Biomarkers & Prevention 03/2014; DOI:10.1158/1055-9965.EPI-13-1057 · 4.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background:Hepatitis B virus (HBV) infection was demonstrated to be a risk factor of several cancers of the digestive system. In addition, liver cirrhosis, which could possibly result from chronic HBV infection, was associated with a higher risk of gastric cancer. However, the association of HBV infection and gastric cancer has not been investigated.Methods:A retrospective case-control study with 580 cases and 580 controls matched for age, sex and year of diagnosis was conducted. The associations between gastric cancer and HBV infection were explored with univariate and multivariate unconditional logistic regression analysis.Results:Hepatitis B surface antigen (HBsAg) was positively associated with gastric cancer (AOR (95% CI): 1.49 (1.06-2.10)). This association remained significant in patients without family history of gastric cancer (AOR (95% CI): (1.06-2.11)). For HBsAg-negative population, being anti-HBc positive/anti-HBs negative, which possibly indicated occult HBV infection, was also found to have some associations with gastric cancer. In addition, some synergistic effects between HBV infection and blood type A in gastric cancer were identified.Conclusions:The HBV infection was positively related with gastric cancer, especially for patients without family history of gastric cancer. Further prospective studies are warranted to confirm this relationship.British Journal of Cancer advance online publication, 19 February 2015; doi:10.1038/bjc.2014.406
    British Journal of Cancer 02/2015; DOI:10.1038/bjc.2014.406 · 4.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: An estimated 16·5 million people worldwide illicitly use opiates, of whom 4 million use raw opium. We did a systematic review to investigate the association between opium use and cancer incidence and mortality. Opium use was associated with an increased risk of cancers of the oesophagus, stomach, larynx, lung, and urinary bladder. Although the present evidence suggests that these associations are possibly causal, further epidemiological studies (particularly prospective studies that collect detailed data about lifetime opium use and control for a broad range of potential confounders) are needed.
    The Lancet Oncology 02/2014; 15(2):e69-e77. DOI:10.1016/S1470-2045(13)70550-3 · 25.12 Impact Factor


Available from
Jul 6, 2014